In this study, we focus on CLN3-Batten disease, which has symptomatic onset between 5–10 years of age; it most often begins with progressive blindness and intractable seizures, followed by cognitive and motor deterioration, and ultimately premature death by the 20s-early 30s [1]. This evidence concerns the gene CLN3 and juvenile neuronal ceroid lipofuscinosis.